Mission statement:
SYNCARE as the CRO of the Second Generation aims to improve the general quality level of international contract research by focussing on lean management concepts and the selection
of highly competent professionals.
SynCare takes CARE
Today outsourcing in clinical research and development is common practice in the pharmaceutical industry. However, the challenge that CROs are faced consists of obtaining reliable results independent from the size of an
operational unit, especially with respect to economic considerations. SYNCARE takes care of the pharmaceutical industry’s needs to develop new drugs even more focussed on quality and cost efficiency. Therefore, specialists from different areas of clinical R&D have been hand selected to work together under one roof: result driven, efficient and international.

The SynCare story
Prior to SYNCARE’s launch in 1998, preparations have been made in order to identify professional companies from within R&D to support this concept. The preparations started in 1995 when contract research just commenced to become popular in Europe. The intention was clearly defined: to improve contract research and to make it even more attractive to the pharmaceutical industry, who have made various experiences with contract research organizations in the past.